1. Home
  2. NTCL vs THRD Comparison

NTCL vs THRD Comparison

Compare NTCL & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCL
  • THRD
  • Stock Information
  • Founded
  • NTCL 2003
  • THRD 2019
  • Country
  • NTCL China
  • THRD United States
  • Employees
  • NTCL N/A
  • THRD N/A
  • Industry
  • NTCL
  • THRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTCL
  • THRD Health Care
  • Exchange
  • NTCL NYSE
  • THRD Nasdaq
  • Market Cap
  • NTCL 193.8M
  • THRD 164.2M
  • IPO Year
  • NTCL 2024
  • THRD 2022
  • Fundamental
  • Price
  • NTCL $28.30
  • THRD $5.15
  • Analyst Decision
  • NTCL
  • THRD Hold
  • Analyst Count
  • NTCL 0
  • THRD 3
  • Target Price
  • NTCL N/A
  • THRD $5.00
  • AVG Volume (30 Days)
  • NTCL 765.5K
  • THRD 1.1M
  • Earning Date
  • NTCL 01-01-0001
  • THRD 05-08-2025
  • Dividend Yield
  • NTCL N/A
  • THRD N/A
  • EPS Growth
  • NTCL N/A
  • THRD N/A
  • EPS
  • NTCL N/A
  • THRD N/A
  • Revenue
  • NTCL $10,101,647.00
  • THRD N/A
  • Revenue This Year
  • NTCL N/A
  • THRD N/A
  • Revenue Next Year
  • NTCL N/A
  • THRD N/A
  • P/E Ratio
  • NTCL N/A
  • THRD N/A
  • Revenue Growth
  • NTCL N/A
  • THRD N/A
  • 52 Week Low
  • NTCL $4.59
  • THRD $3.18
  • 52 Week High
  • NTCL $51.80
  • THRD $16.94
  • Technical
  • Relative Strength Index (RSI)
  • NTCL N/A
  • THRD 76.76
  • Support Level
  • NTCL N/A
  • THRD $5.11
  • Resistance Level
  • NTCL N/A
  • THRD $5.25
  • Average True Range (ATR)
  • NTCL 0.00
  • THRD 0.05
  • MACD
  • NTCL 0.00
  • THRD -0.04
  • Stochastic Oscillator
  • NTCL 0.00
  • THRD 27.54

About NTCL NETCLASS TECHNOLOGY INC

Netclass Technology Inc is a business-to-business smart education specialist, providing IT solutions to schools, training institutions, corporations, public agencies and other institutions or corporate customers. It offers SaaS subscription service and application development. The solution's modules include teaching management, campus management, online teaching, online examination, epidemic prevention and control, education credit blockchain system, and lecturer evaluation services.

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Share on Social Networks: